Breakthrough Invasive Fungal Infections in Patients With High-Risk Hematological Disorders Receiving Voriconazole and Posaconazole Prophylaxis: A Systematic Review
HematologiaSobre o estudo
- Desenho
- Revisão sistemática
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
- Publicado em
- 19 jul 2024
- Citações
- 73
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Breakthrough Invasive Fungal Infections in Patients With High-Risk Hematological Disorders Receiving Voriconazole and Posaconazole Prophylaxis: A Systematic Review
Catherine-Audrey Boutin, Florence Durocher, Stéphanie Beauchemin, Daniela Ziegler, Claire Nour Abou Chakra, Simon Frédéric Dufresne
Descritores MeSH
- Invasive Fungal Infections
- Antifungal Agents
- Hematologic Diseases
- Triazoles
- Voriconazole
- Aspergillus
- Drug Resistance, Fungal
- Humans
Veja também
Estudos relacionados
- Analysis of Susceptibility and Drug Resistance of Antifungal Agents in Aspergillosis and Mucormycosis Patients: A Systematic Review
- Comparative efficacy and safety of antifungal prophylactic agents in allogeneic hematopoietic stem cell transplantation: A systematic review and network meta-analysis
- Efficacy and safety of isavuconazole for invasive fungal infections: A systematic review and meta-analysis of randomized controlled trials
- Efficacy and safety of isavuconazole versus voriconazole for the treatment of invasive fungal infections: a meta-analysis with trial sequential analysis
- Epidemiologia da infecção fúngica invasiva na leucemia aguda para informar a prática de prevenção e vigilância da infecção: Uma revisão sistemática e metanálises